Post-approval studies (Phase 4)Study completedNCT02255656
What this trial is testing
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
Who this might be right for
Relapsing Remitting Multiple Sclerosis
Genzyme, a Sanofi Company 1,062